|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Cytomedix Inc. (CYDX) Secures Second DePuy Spine Licensing Agreement
10/19/2005 5:12:57 PM
ROCKVILLE, Md., March 8, 2005 (PRIMEZONE) -- Cytomedix, Inc. (OTCBB:CYME) today announced that it has entered into a second licensing agreement with DePuy Spine, Inc., a Johnson and Johnson company. The additional license of Cytomedix's Knighton patent (US Patent No. 5,165,938) is for all applications of its autologous platelet releasate therapy, excluding treatment of chronic wounds, such as pressure ulcers, venous stasis or diabetic foot ulcers.
The company also said that DePuy Spine's existing exclusive licensing agreement for spinal, orthopedic and neurosurgical applications would be converted to a non-exclusive license to practice in those fields. Financial details of the new agreement were not disclosed.
|
|
|
|
|
|
|
|
|
|
|